L1CAM in human cancer
L1 cell adhesion molecule (L1CAM) is one of the first neural adhesion molecules described with important functions in the development of the nervous system. Subsequent work discovered that L1CAM is expressed in many human cancers and is often associated with bad prognosis. This is most likely due to...
Saved in:
| Main Authors: | , , |
|---|---|
| Format: | Article (Journal) |
| Language: | English |
| Published: |
2016
|
| In: |
International journal of cancer
Year: 2015, Volume: 138, Issue: 7, Pages: 1565-1576 |
| ISSN: | 1097-0215 |
| DOI: | 10.1002/ijc.29658 |
| Online Access: | Verlag, Volltext: https://doi.org/10.1002/ijc.29658 Verlag, Volltext: https://onlinelibrary-wiley-com.ezproxy.medma.uni-heidelberg.de/doi/abs/10.1002/ijc.29658 
|
| Author Notes: | Peter Altevogt, Kai Doberstein and Mina Fogel |
MARC
| LEADER | 00000caa a2200000 c 4500 | ||
|---|---|---|---|
| 001 | 1662521669 | ||
| 003 | DE-627 | ||
| 005 | 20220816123330.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 190328r20162015xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1002/ijc.29658 |2 doi | |
| 035 | |a (DE-627)1662521669 | ||
| 035 | |a (DE-599)KXP1662521669 | ||
| 035 | |a (OCoLC)1341205587 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 041 | |a eng | ||
| 084 | |a 33 |2 sdnb | ||
| 100 | 1 | |a Altevogt, Peter |d 1947- |e VerfasserIn |0 (DE-588)1113206306 |0 (DE-627)867118784 |0 (DE-576)164729240 |4 aut | |
| 245 | 1 | 0 | |a L1CAM in human cancer |c Peter Altevogt, Kai Doberstein and Mina Fogel |
| 264 | 1 | |c 2016 | |
| 300 | |a 12 | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Gesehen am 28.03.2019 | ||
| 500 | |a Online 24 June 2015 | ||
| 520 | |a L1 cell adhesion molecule (L1CAM) is one of the first neural adhesion molecules described with important functions in the development of the nervous system. Subsequent work discovered that L1CAM is expressed in many human cancers and is often associated with bad prognosis. This is most likely due to the motility and invasion promoting function of L1CAM. Here, we describe the path L1CAM has taken from a neural adhesion molecule to a recognized tumor antigen. We summarize the literature on L1CAM expression in cancers and pre-cancerous lesions. We focus on the genetic elements required for its re-expression and highlight preclinical studies for targeted therapy. The data suggest that L1CAM is a valuable diagnostic/prognostic marker and an attractive target for the therapy of several human cancers. | ||
| 534 | |c 2015 | ||
| 650 | 4 | |a immunohistochemistry | |
| 650 | 4 | |a L1CAM | |
| 650 | 4 | |a therapy model | |
| 650 | 4 | |a tumor therapy | |
| 700 | 1 | |a Doberstein, Kai |d 1982- |e VerfasserIn |0 (DE-588)1032164670 |0 (DE-627)73800040X |0 (DE-576)379866285 |4 aut | |
| 700 | 1 | |a Fogel, Mina |e VerfasserIn |0 (DE-588)1182003354 |0 (DE-627)1662521316 |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t International journal of cancer |d Bognor Regis : Wiley-Liss, 1966 |g 138(2016), 7, Seite 1565-1576 |h Online-Ressource |w (DE-627)269532781 |w (DE-600)1474822-8 |w (DE-576)079876129 |x 1097-0215 |7 nnas |a L1CAM in human cancer |
| 773 | 1 | 8 | |g volume:138 |g year:2016 |g number:7 |g pages:1565-1576 |g extent:12 |a L1CAM in human cancer |
| 856 | 4 | 0 | |u https://doi.org/10.1002/ijc.29658 |x Verlag |x Resolving-System |3 Volltext |
| 856 | 4 | 0 | |u https://onlinelibrary-wiley-com.ezproxy.medma.uni-heidelberg.de/doi/abs/10.1002/ijc.29658 |x Verlag |3 Volltext |
| 951 | |a AR | ||
| 992 | |a 20190328 | ||
| 993 | |a Article | ||
| 994 | |a 2016 | ||
| 998 | |g 1113206306 |a Altevogt, Peter |m 1113206306:Altevogt, Peter |d 60000 |d 61900 |d 50000 |e 60000PA1113206306 |e 61900PA1113206306 |e 50000PA1113206306 |k 0/60000/ |k 1/60000/61900/ |k 0/50000/ |p 1 |x j | ||
| 999 | |a KXP-PPN1662521669 |e 3417301335 | ||
| BIB | |a Y | ||
| SER | |a journal | ||
| JSO | |a {"relHost":[{"type":{"bibl":"periodical","media":"Online-Ressource"},"part":{"text":"138(2016), 7, Seite 1565-1576","year":"2016","extent":"12","volume":"138","pages":"1565-1576","issue":"7"},"id":{"doi":["10.1002/(ISSN)1097-0215"],"zdb":["1474822-8"],"eki":["269532781"],"issn":["1097-0215"]},"physDesc":[{"extent":"Online-Ressource"}],"note":["Gesehen am 28.02.08","Darin: Predictive oncology"],"pubHistory":["1.1966 -"],"corporate":[{"roleDisplay":"Herausgebendes Organ","role":"isb","display":"International Union against Cancer"}],"title":[{"title_sort":"International journal of cancer","title":"International journal of cancer","subtitle":"publication of the International Union against Cancer (UICC) = Journal international du cancer"}],"language":["eng"],"recId":"269532781","disp":"L1CAM in human cancerInternational journal of cancer","origin":[{"dateIssuedDisp":"1966-","publisherPlace":"Bognor Regis","publisher":"Wiley-Liss","dateIssuedKey":"1966"}],"titleTranslated":[{"translated":"Journal international du cancer"}],"titleAlt":[{"title":"Predictive oncology"}]}],"type":{"media":"Online-Ressource","bibl":"article-journal"},"note":["Gesehen am 28.03.2019"," Online 24 June 2015"],"id":{"doi":["10.1002/ijc.29658"],"eki":["1662521669"]},"physDesc":[{"extent":"12 S."}],"name":{"displayForm":["Peter Altevogt, Kai Doberstein and Mina Fogel"]},"title":[{"title_sort":"L1CAM in human cancer","title":"L1CAM in human cancer"}],"person":[{"display":"Altevogt, Peter","family":"Altevogt","role":"aut","given":"Peter","roleDisplay":"VerfasserIn"},{"roleDisplay":"VerfasserIn","family":"Doberstein","display":"Doberstein, Kai","given":"Kai","role":"aut"},{"given":"Mina","role":"aut","family":"Fogel","display":"Fogel, Mina","roleDisplay":"VerfasserIn"}],"language":["eng"],"origin":[{"dateIssuedKey":"2016","dateIssuedDisp":"2016"}],"recId":"1662521669"} | ||
| SRT | |a ALTEVOGTPEL1CAMINHUM2016 | ||